CHEMOCENTRYX

chemocentryx-logo

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.

#SimilarOrganizations #People #Financial #Event #Website #More

CHEMOCENTRYX

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
1997-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.chemocentryx.com

Total Employee:
101+

Status:
Active

Contact:
+1.650.210.2900

Email Addresses:
[email protected]

Total Funding:
634.34 M USD

Technology used in webpage:
SPF SSL By Default Mobile Non Scaleable Content Amazon IPv6 Google Maps ReCAPTCHA Microsoft Azure DNS Google Maps API Apple Mobile Web App Capable


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

gelesis-logo

Gelesis

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

myomo-logo

Myomo

Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.


Current Advisors List

geoffrey-parker_image

Geoffrey Parker Board of Directors @ ChemoCentryx
Board_member

Current Employees Featured

rita-i-jain_image

Rita I. Jain
Rita I. Jain EVP & Chief Medical Officer @ ChemoCentryx
EVP & Chief Medical Officer
2021-10-01

sangita-ghosh_image

Sangita Ghosh
Sangita Ghosh Senior Vice President, Technical Operations @ ChemoCentryx
Senior Vice President, Technical Operations

not_available_image

Markus J. Cappel
Markus J. Cappel Chief Business Officer and Treasurer @ ChemoCentryx
Chief Business Officer and Treasurer

dalia-rayes_image

Dalia Rayes
Dalia Rayes Senior Vice President, Head of Commercial @ ChemoCentryx
Senior Vice President, Head of Commercial

not_available_image

Susan M. Kanaya
Susan M. Kanaya Senior Vice President, Finance, Chief Financial Officer and Secretary @ ChemoCentryx
Senior Vice President, Finance, Chief Financial Officer and Secretary

gopi-kurse_image

Gopi Kurse
Gopi Kurse Vice President, Quality @ ChemoCentryx
Vice President, Quality
2020-06-01

kari-leetch_image

Kari Leetch
Kari Leetch Senior Vice President, Human Resources @ ChemoCentryx
Senior Vice President, Human Resources

not_available_image

Thomas J. Schall
Thomas J. Schall Founder, President, Chief Executive Officer and Chairman of the Board @ ChemoCentryx
Founder, President, Chief Executive Officer and Chairman of the Board

not_available_image

Catherine L. Kelleher
Catherine L. Kelleher Senior Vice President, Clinical Development @ ChemoCentryx
Senior Vice President, Clinical Development
2019-01-01

not_available_image

Jan L Hillson
Jan L Hillson Senior Vice President, Drug Development @ ChemoCentryx
Senior Vice President, Drug Development
2016-01-01

Founder


not_available_image

Thomas J. Schall

Stock Details


Company's stock symbol is NASDAQ:CCXI

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - ChemoCentryx

alta-partners_image

Alta Partners

Alta Partners investment in Series E - ChemoCentryx

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series E - ChemoCentryx

glaxo-group_image

Glaxo Group

Glaxo Group investment in Series E - ChemoCentryx

healthcap_image

HealthCap

HealthCap investment in Series E - ChemoCentryx

glaxo-group_image

Glaxo Group

Glaxo Group investment in Series D - ChemoCentryx

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series D - ChemoCentryx

gimv_image

Gimv

Gimv investment in Series D - ChemoCentryx

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series D - ChemoCentryx

alta-partners_image

Alta Partners

Alta Partners investment in Series D - ChemoCentryx

Official Site Inspections

http://www.chemocentryx.com Semrush global rank: 4.64 M Semrush visits lastest month: 2.14 K

  • Host name: cloudproxy10158.sucuri.net
  • IP address: 192.124.249.158
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ChemoCentryx" on Search Engine